Steris (STE)

• Market cap: $21.6B
• 1 day: 0.49%
• 5 days: 0.89%
• 1 month: 0.39%
• 3 months: 3.07%
• 6 months: 1.23%
• Year to date: 10.57%
• 1 year: 8.68%
• 5 years: 49.80%
• 10 years: 216.65%
• Sector: Healthcare
• Industry: Medical Devices

About: Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

Employees: 18,179

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

436% more call options, than puts

Call options by funds: $8.59M | Put options by funds: $1.6M

18% more first-time investments, than exits

New positions opened: 92 | Existing positions closed: 78

0% more funds holding

Funds holding: 750 [Q3] → 752 (+2) [Q4]

1.35% less ownership

Funds ownership: 94.15% [Q3] → 92.8% (-1.35%) [Q4]

13% less funds holding in top 10

Funds holding in top 10: 8 [Q3] → 7 (-1) [Q4]

15% less capital invested

Capital invested by funds: $22.2B [Q3] → $18.8B (-$3.41B) [Q4]

16% less repeat investments, than reductions

Existing positions increased: 253 | Existing positions reduced: 302

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $240 7% upside
• Avg. target: $259 16% upside
• High target: $265 18% upside

4 analyst ratings

• positive: 4 100%
• neutral: 0 0%
• negative: 0 0%

JMP Securities David Turkaly 26% 1-year accuracy 7 / 27 met price target	18% upside $265	Market Outperform Reiterated	10 Apr 2025
JMP Securities Reni Benjamin 15% 1-year accuracy 6 / 40 met price target	18% upside $265	Market Outperform Reiterated	6 Feb 2025
Stephens & Co. Jacob Johnson 23% 1-year accuracy 3 / 13 met price target	7% upside $240	Overweight Reiterated	6 Feb 2025
Piper Sandler Jason Bednar 18% 1-year accuracy 7 / 38 met price target	18% upside $265	Overweight Maintained	3 Feb 2025